NUWE today
$5.53+$0.29 (+5.53%)close Nov 11, 2026Trend
DailyDowntrend (confirmed)
4 hourStrong Bullish
1 hourStrong Bullish
15 minStrong Bullish
5 minStrong Bullish
Daily trend turns up above $1.46
Key levels
Resistance$28734.83
Resistance$7.15
Support$3.34
Support$1.46
Latest news & SEC filings
EarningsNuwellis Posts Wider Q3 Loss, Revenue Below Estimates
ProductNuwellis files 510(k) with FDA for pediatric indication expansion
ProductNuwellis files 510(k) with FDA to widen Aquadex SmartFlow use to children 5 kg and up
All NUWE news →About Nuwellis
Nuwellis develops, manufactures, and commercializes medical devices for ultrafiltration therapy, primarily the Aquadex FlexFlow and Aquadex SmartFlow systems. These devices remove excess fluid from patients with fluid overload who have not responded to diuretics, and are used in pediatric, critical care, and heart failure settings. The company sells to hospitals and healthcare providers in the United States and international markets.
Based on the company's 10-K filed Mar 11, 2026.
Nasdaq · Healthcare
Nuwellis, Inc. (NUWE)
What Is the Price Target for NUWE?
SEPT Low Target
$0.00
SEPT Mid Target
$0.00
SEPT High Target
$0.00
Analyst Consensus
$0.00
Is NUWE a Buy or Sell Right Now?
Thesis
- •Revenue growing -5.4% YoY with DECLINING trend — consistent growth.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for NUWE.
Start Free Trial →Is NUWE Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
P/B, PEG
Fair Value
$1.81
22
Moat Score
NONE
2/9
Piotroski Score
-76.5
Altman Z-Score
What Is Smart Money Doing with NUWE?
Insider Signal
NEUTRAL
0 buys / 0 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
LOW
Signal: NEUTRAL
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →NUWE Growth Story
Revenue YoY
-5.4%
3yr Revenue CAGR
N/A%
EPS Growth YoY
92.81%
FCF Growth YoY
-12.9%
Revenue Trend
DECLINING
Dark Pool Trades for NUWE
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for NUWE, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 18:22:56 | $5.59 | 1,000 | $$6K | SELL |
| 16:50:13 | $5.50 | 1,000 | $$6K | BUY |
| 16:40:02 | $5.49 | 1,000 | $$5K | BUY |
| 16:33:13 | $5.49 | 1,000 | $$5K | BUY |
| 15:52:11 | $5.45 | 3,000 | $$16K | BUY |
5 dark pool trades shown · $$38K preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for Nuwellis, Inc. (NUWE) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →NUWE — frequently asked questions
What is NUWE stock price today?
Nuwellis, Inc. (NUWE) is at $5.53, up 5.53% (+$0.29) at the Nov 11, 2026 close.
Why is NUWE stock moving today?
Latest NUWE news — Nov 12, 2026: Nuwellis Posts Wider Q3 Loss, Revenue Below Estimates · Nov 5, 2026: Nuwellis files 510(k) with FDA for pediatric indication expansion
Did NUWE beat earnings?
NUWE last reported on Aug 13, 2026: EPS -$26.64 vs -$23.80 expected — a miss of 11.9%.
Does NUWE pay a dividend?
NUWE does not currently pay a dividend.
What are NUWE support and resistance levels?
Support: $3.34, $1.46, $0.28. Resistance: $7.15, $28734.83, $37558.50.
What are insiders doing with NUWE?
Insider activity: NEUTRAL, 0 buys and 0 sells in the last 90 days.
What is the latest news on NUWE?
Nov 12, 2026: Nuwellis Posts Wider Q3 Loss, Revenue Below Estimates · Nov 5, 2026: Nuwellis files 510(k) with FDA for pediatric indication expansion · Nov 5, 2026: Nuwellis files 510(k) with FDA to widen Aquadex SmartFlow use to children 5 kg and up